IMNM
IMNM
US45257U1088
Immunome, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 6.941.000 9.041.000
23.2%
Cost of Revenue -- --
--
Gross Profit -- --
--
231.054.000 162.497.000
42.2%
Operating Income -224.113.000 -153.456.000
46.0%
Pretax Income -212.394.000 -292.963.000
27.5%
Net Income Common Stockholders -212.394.000 -292.963.000
27.5%
-- --
--
-- --
--
ende